Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
879 Results for "
Targeting peptide
" in MedChemExpress (MCE) Product Catalog:
Products (879)
879 Results for "Targeting peptide" in MCE Product Catalog:
Cat. No.: HY-W348072
CAS No.: 850786-33-3
SARS-CoV-2-IN-59 (compound E07), an imidazoline derivative, is a non-peptide small molecule inhibitor of SARS-CoV-2 that targets the main protease (Mpro) of the coronavirus. SARS-CoV-2-IN-59 has a strong interaction with residues on Mpro (Met 165, Gln 166, Met 165, His 41, Gln 189) .
Cat. No.: HY-L255
72 compounds
Dipeptide compounds have attracted extensive attention in drug discovery and life science research due to their simple structures, ease of modification, and favorable biocompatibility. As small peptides composed of two amino acids, dipeptides exhibit diverse biological activities, including anti-inflammatory, antioxidant, antimicrobial, anticancer, and immunomodulatory effects, showing significant application potential in metabolic disorders, neurological diseases, and cancer research. Compared with traditional small molecules, dipeptide compounds possess favorable target-binding properties and high structural plasticity, making them valuable tools for drug screening and mechanism studies.
The MCE Dipeptide Compound Library contains 72 dipeptide compounds and can be applied to peptide drug discovery and development.
Cat. No.: HY-184566A
Target:
Research Areas:
DPPE-PEG2000-iRGD is a functionalized PEGylated lipid conjugate composed of three modular components: dipalmitoylphosphatidylethanolamine (DPPE) as the lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and iRGD peptide (HY-P0122) as the terminal targeting/functional ligand. DPPE-PEG2000-iRGD can be incorporated into liposomes, lipid nanoparticles (LNPs), or other nanocarriers to confer ligand-directed targeting capability against sequential binding to αv integrins on tumor vasculature → neuropilin-1 (NRP1) in tumor tissue.
Cat. No.: HY-184567A
Target:
Research Areas:
DSG-PEG2000-iRGD is a functionalized PEGylated lipid conjugate composed of three modular components: distearoylglycerol (DSG) as the lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and iRGD peptide (HY-P0122) as the terminal targeting/functional ligand. DSG-PEG2000-iRGD can be incorporated into liposomes, lipid nanoparticles (LNPs), or other nanocarriers to confer ligand-directed targeting capability against sequential binding to αv integrins on tumor vasculature → neuropilin-1 (NRP1) in tumor tissue.
Cat. No.: HY-184576
Target:
Research Areas:
DOPE-PEG1000-iRGD is a functionalized PEGylated lipid conjugate composed of three modular components: dioleoylphosphatidylethanolamine (DOPE) as the lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 1000 Da, and iRGD peptide (HY-P0122) as the terminal targeting/functional ligand. DOPE-PEG1000-iRGD can be incorporated into liposomes, lipid nanoparticles (LNPs), or other nanocarriers to confer ligand-directed targeting capability against sequential binding to αv integrins on tumor vasculature → neuropilin-1 (NRP1) in tumor tissue.
Cat. No.: HY-184576A
Target:
Research Areas:
DOPE-PEG2000-iRGD is a functionalized PEGylated lipid conjugate composed of three modular components: dioleoylphosphatidylethanolamine (DOPE) as the lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and iRGD peptide (HY-P0122) as the terminal targeting/functional ligand. DOPE-PEG2000-iRGD can be incorporated into liposomes, lipid nanoparticles (LNPs), or other nanocarriers to confer ligand-directed targeting capability against sequential binding to αv integrins on tumor vasculature → neuropilin-1 (NRP1) in tumor tissue.
Cat. No.: HY-184576B
Target:
Research Areas:
DOPE-PEG3400-iRGD is a functionalized PEGylated lipid conjugate composed of three modular components: dioleoylphosphatidylethanolamine (DOPE) as the lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 3400 Da, and iRGD peptide (HY-P0122) as the terminal targeting/functional ligand. DOPE-PEG3400-iRGD can be incorporated into liposomes, lipid nanoparticles (LNPs), or other nanocarriers to confer ligand-directed targeting capability against sequential binding to αv integrins on tumor vasculature → neuropilin-1 (NRP1) in tumor tissue.
Cat. No.: HY-184576C
Target:
Research Areas:
DOPE-PEG5000-iRGD is a functionalized PEGylated lipid conjugate composed of three modular components: dioleoylphosphatidylethanolamine (DOPE) as the lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 5000 Da, and iRGD peptide (HY-P0122) as the terminal targeting/functional ligand. DOPE-PEG5000-iRGD can be incorporated into liposomes, lipid nanoparticles (LNPs), or other nanocarriers to confer ligand-directed targeting capability against sequential binding to αv integrins on tumor vasculature → neuropilin-1 (NRP1) in tumor tissue.
Cat. No.: HY-184577
Target:
Research Areas:
DMG-PEG1000-iRGD is a functionalized PEGylated lipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as the lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 1000 Da, and iRGD peptide (HY-P0122) as the terminal targeting/functional ligand. DMG-PEG1000-iRGD can be incorporated into liposomes, lipid nanoparticles (LNPs), or other nanocarriers to confer ligand-directed targeting capability against sequential binding to αv integrins on tumor vasculature → neuropilin-1 (NRP1) in tumor tissue.
Cat. No.: HY-184577A
Target:
Research Areas:
DMG-PEG2000-iRGD is a functionalized PEGylated lipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as the lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and iRGD peptide (HY-P0122) as the terminal targeting/functional ligand. DMG-PEG2000-iRGD can be incorporated into liposomes, lipid nanoparticles (LNPs), or other nanocarriers to confer ligand-directed targeting capability against sequential binding to αv integrins on tumor vasculature → neuropilin-1 (NRP1) in tumor tissue.
Cat. No.: HY-184577B
Target:
Research Areas:
DMG-PEG3400-iRGD is a functionalized PEGylated lipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as the lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 3400 Da, and iRGD peptide (HY-P0122) as the terminal targeting/functional ligand. DMG-PEG3400-iRGD can be incorporated into liposomes, lipid nanoparticles (LNPs), or other nanocarriers to confer ligand-directed targeting capability against sequential binding to αv integrins on tumor vasculature → neuropilin-1 (NRP1) in tumor tissue.
Cat. No.: HY-184577C
Target:
Research Areas:
DMG-PEG5000-iRGD is a functionalized PEGylated lipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as the lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 5000 Da, and iRGD peptide (HY-P0122) as the terminal targeting/functional ligand. DMG-PEG5000-iRGD can be incorporated into liposomes, lipid nanoparticles (LNPs), or other nanocarriers to confer ligand-directed targeting capability against sequential binding to αv integrins on tumor vasculature → neuropilin-1 (NRP1) in tumor tissue.
Cat. No.: HY-187727A
Synonyms: DPPE-PEG2000-Mal-Cys-NGR
Target:
Research Areas:
DPPE-PEG2000-NGR (DPPE-PEG2000-Mal-Cys-NGR) is a functionalized PEGylated phospholipid conjugate composed of three modular components: 1,2-dipalmitoyl-sn-glycerol-3-phosphate ethanolamine (DPPE) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an NGR (HY-P1043) peptide as a terminal targeting/functional ligand. DPPE-PEG2000-NGR can be used for tumor angiogenesis-targeted drug delivery .
Cat. No.: HY-187743A
Synonyms: DPPE-PEG2000-Mal-Cys-KTLLPTP
Target:
Research Areas:
DPPE-PEG2000-PTP (DPPE-PEG2000-Mal-Cys-KTLLPTP) is a functionalized PEGylated phospholipid conjugate composed of three modular components: 1,2-dipalmitoyl-sn-glycerol-3-phosphate ethanolamine (DPPE) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a PTP (HY-P11850) peptide as a terminal targeting/functional ligand. DPPE-PEG2000-PTP can be used in research on targeted drug delivery for pancreatic cancer .
Cat. No.: HY-187745A
Synonyms: DPPE-PEG2000-Mal-Cys-ASSLNIA
Target:
Research Areas:
DPPE-PEG2000-MTP (DPPE-PEG2000-Mal-Cys-ASSLNIA) is a functionalized PEGylated phospholipid conjugate composed of three modular components: 1,2-dipalmitoyl-sn-glycerol-3-phosphate ethanolamine (DPPE) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an MTP (HY-P10643) peptide as a terminal targeting/functional ligand. DPPE-PEG2000-MTP can be used in research on muscle-targeted drug delivery and muscle tissue gene delivery .
Cat. No.: HY-187753A
Synonyms: DPPE-PEG2000-Mal-Cys-TAASGVRSMH
Target:
Research Areas:
DPPE-PEG2000-TAASGVRSMH (DPPE-PEG2000-Mal-Cys-TAASGVRSMH) is a functionalized PEGylated phospholipid conjugate composed of three modular components: 1,2-dispalmitoyl-sn-glycerol-3-phosphate ethanolamine (DPPE) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and the TAASGVRSMH (HY-P10989) peptide as a terminal targeting/functional ligand. DPPE-PEG2000-TAASGVRSMH can be used in research on tumor-targeted drug delivery, among other applications .
Cat. No.: HY-187754A
Synonyms: DPPE-PEG2000-Mal-Cys-HTMYYHHYQHHL
Target:
Research Areas:
DPPE-PEG2000-K237 (DPPE-PEG2000-Mal-Cys-HTMYYHHYQHHL) is a functionalized PEGylated phospholipid conjugate composed of three modular components: 1,2-dipalmitoyl-sn-glycerol-3-phosphate ethanolamine (DPPE) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a K237 peptide as a terminal targeting/functional ligand. DPPE-PEG2000-K237 can be used in research on tumor-targeted drug delivery .
Cat. No.: HY-187774A
Synonyms: DPPE-PEG2000-Mal-Cys-DDDDDD
Target:
Research Areas:
DPPE-PEG2000-Asp6 (DPPE-PEG2000-Mal-Cys-DDDDDD) is a functionalized PEGylated phospholipid conjugate composed of three modular components: 1,2-dipalmitoyl-sn-glycerol-3-phosphate ethanolamine (DPPE) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an Asp6 peptide as a terminal targeting/functional ligand. DPPE-PEG2000-Asp6 can be used in research such as bone-targeted drug delivery .
Cat. No.: HY-187778A
Synonyms: DPPE-PEG2000-Mal-Cys-RAGLQFPVGRLLRRLLR
Target:
Research Areas:
DPPE-PEG2000-BR2 (DPPE-PEG2000-Mal-Cys-RAGLQFPVGRLLRRLLR) is a functionalized PEGylated phospholipid conjugate composed of three modular components: 1,2-dispalmitoyl-sn-glycerol-3-phosphate ethanolamine (DPPE) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a BR2 peptide as a terminal targeting/functional ligand. DPPE-PEG2000-BR2 can be used in research on targeted drug delivery for breast cancer .
Cat. No.: HY-187784A
Synonyms: DPPE-PEG2000-Mal-Cys-CREKA
Target:
Research Areas:
DPPE-PEG2000-CREKA (DPPE-PEG2000-Mal-Cys-CREKA) is a functionalized PEGylated phospholipid conjugate composed of three modular components: 1,2-dipalmitoyl-sn-glycerol-3-phosphate ethanolamine (DPPE) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a CREKA (HY-P10709) peptide as a terminal targeting/functional ligand. DPPE-PEG2000-CREKA can be used in research on tumor angiogenesis-targeted drug delivery, among other applications .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
